Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Journal Mobile Options
Table of Contents
Vol. 82, No. 3, 2008
Issue release date: October 2008
Section title: Review
Free Access
Pharmacology 2008;82:171–179

The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel Prize

Bosch F.a, b · Rosich L.a
aEsteve Foundation, and bDepartment of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
email Corresponding Author

Fèlix Bosch

Esteve Foundation

Llobet i Vall-Llosera, 2

ES–08032 Barcelona (Spain)

Tel. +34 934 335 320, Fax +34 934 504 899, E-Mail fbosch@esteve.org


  1. Official Website of the Nobel Foundation. Stockholm, 2008. http://nobelprize.org (accessed May 5, 2008).
  2. Rubin RP: A brief history of great discoveries in pharmacology: in celebration of the centennial anniversary of the founding of the American Society of Pharmacology and Experimental Therapeutics. Pharmacol Rev 2007;59:289–359.
  3. Kaufmann SHE: Paul Ehrlich: founder of chemotherapy. Nat Rev Drug Discov 2008;7:373.
  4. Silverman M: Kill the Germs! Lister to Ehrlich to 205. Magic in a Bottle. New York, MacMillan, 1942, pp 134–168.
  5. Mann J: The Elusive Magic Bullet. The Search for the Perfect Drug. New York, Oxford University Press, 1999, pp 1–209.
  6. Kasten FH: Paul Ehrlich: pathfinder in cell biology. 1. Chronicle of his life and accomplishments in immunology, cancer research, and chemotherapy. Biotech Histochem 1996;71:2–37.
  7. Venita J: A portrait of history: Paul Ehrlich. Arch Pathol Lab Med 2001;125:724.
    External Resources
  8. Crivellato E, Beltrami CA, Mallardi F, Ribatti D: Paul Ehrlich’s doctoral thesis: a milestone in the study of mast cells. Br J Haematol 2003;123:19–21.
  9. Riethmiller S: From Atoxyl to Salvarsan: searching for the magic bullet. Chemotherapy 2005;51:234–242.
  10. Paul Ehrlich. Langen, Paul-Ehrlich-Institut. http://www.pei.de/cln_046/nn_162438/EN/institute-en/paul-ehrlich-en/paul-ehrlich-node-en.html?__nnn=true (accessed May 5, 2008).
  11. Parascandola J: The theoretical basis of Paul Ehrlich’s chemotherapy. J Hist Med Allied Sci 1981;36:19–43.
  12. Kristiansen JE: Dyes, antipsychotic drugs, and antimicrobial activity. Fragments of a development, with special reference to the influence of Paul Ehrlich. Dan Med Bull 1989;36:178–185.
  13. Winau F, Westphal O, Winau R: Paul Ehrlich – In search of the magic bullet. Microbes Infect 2004;6:786–789.
  14. Schwartz RS: Paul Ehrlich’s magic bullets. N Engl J Med 2004;350:1079–1080.
  15. Weatheral M: In Search of a Cure. New York, Oxford University Press, 1999.
  16. Witkop B: Paul Ehrlich and his magic bullets – Revisited. Proc Am Philos Soc 1999;143:540–557.
  17. Bennett MR: The concept of transmitter receptors: 100 years on. Neuropharmacology 2000;39:523–546.
  18. Akatsu S, Noguchi H: The drug-fastness of spirochetes to arsenic, mercurial, and iodide compounds in vitro. J Exp Med 1917;25:349–362.
  19. Krantz JC Jr: Paul Ehrlich and ‘The Magic Bullet’, Arsphenamine. Historical Medical Classics Involving New Drugs. Baltimore, Williams & Wilkins, 1974, pp 51–57.
  20. Felsenfeld O: K. Shiga, bacteriologist. Science 1957;126:113.
  21. Sneader W: Drug Discovery: A History. Chichester, Wiley, 2005.
  22. Jolliffe DM: A history of the use of arsenicals in man. J R Soc Med 1993;86:287–289.
  23. Drews J: Paul Ehrlich: magister mundi. Nat Rev Drug Discov 2004;3:797–801.
  24. Gensini GF, Conti AA, Lippi D: The contributions of Paul Ehrlich to infectious disease. J Infect 2007;54:221–224.
  25. Marlow FW Jr: Syphilis then and now. JAMA 1974;230:1320–1321.
  26. Jaouen G, Beck W, McGlinchey MJ: A Novel Field of Research: Bioorganometallic Chemistry, Origins, and Founding Principles. Weinheim, Wiley-VCH, 2006, pp 1–37.
  27. Montes J, Cueva J: Ehrlich, su vida y su obra. Alergia 1967;15:29–42.
  28. Cowley AH, Lasch JG, Norman NC, Pakulski M: Synthesis and structure of a diarsene: the first compound with an unsupported arsenic-arsenic double bond. J Am Chem Soc 1983;105:5506–5507.
  29. Lloyd NC, Morgan H, Nicholson BK, Ronimus RS: The composition of Ehrlich’s salvarsan: resolution of a century-old debate. Angew Chem Int Ed Engl 2005;44:941–944.
  30. Raju TNK: The Nobel chronicles. 1908: Elie Metchnikoff (1845–1916), Paul Ehrlich (1854–1915). Lancet 1998;352:661.
  31. Jacobs MS: Paul Ehrlich and his relation to modern chemotherapy. Bull Hist Med 1940;8:956–964.
  32. Silverstein AM: Paul Ehrlich, archives and the history of immunology. Nat Immunol 2005;6:639.
  33. Cowen DL, Segelman AB: Antibiotics in Historical Perspective. New Jersey, Merck Sharp & Dohme, 1981.